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A B S T R A C T
To remedy carotid artery stenosis and prevent stroke surgical intervention is commonly used, and the gold
standard being carotid endarterectomy (CEA). During CEA cerebrovascular hemoglobin oxygen saturation de-
creases and when this decrease reaches critical levels it leads to cerebral hypoxia that causes neuronal damage.
One of the proposed mechanism that affects changes during CEA and contribute to acute brain ischemia (ABI) is
oxidative stress. The increased production of reactive oxygen species and reactive nitrogen species during ABI
may cause an unregulated inflammatory response and further lead to structural and functional injury of neurons.
Antioxidant activity are involved in the protection against neuronal damage after cerebral ischemia. We hy-
pothesized that neuronal injury and poor outcomes in patients undergoing CEA may be results of oxidative stress
that disturbed function of antioxidant enzymes and contributed to the DNA damage in lymphocytes.
Background to hypothesis
Acute brain ischemia (ABI) is a neurological condition that most
frequently occurs due to sudden carotid artery occlusion that either
prevents or dramatically reduces blood flow to the brain [1]. The re-
duced blood flow lowers the oxygen supply to the brain that leads to
cerebral hypoxia and consequently, the death of brain tissue or stroke
[2]. To remedy carotid artery stenosis, and prevent stroke surgical in-
tervention is commonly used, the gold standard being carotid en-
darterectomy (CEA) [3,4]. Despite the great performance of this sur-
gical procedure, tissue injury that can occur as a result of ischemia and
reperfusion in patients with carotid artery stenosis may contribute to
instances with poor clinical outcome. It was reported that cere-
brovascular hemoglobin oxygen saturation (Sco2) decreases in patients
undergoing CEA and Sco2 dropping below a critical level leads to hy-
poxia [5–7]. Thus, CEA affects changes in the underlying molecular
mechanisms that facilitate ABI in patients with carotid artery stenosis.
Statement of the hypothesis
Mitochondrial dysfunction and the free radical generation that leads
to oxidative stress have been associated with ABI [8]. A few mechan-
isms have been proposed for generation of free radicals during ABI,
such as glutamate stimulation of n-methyl-d-aspartate receptors, acti-
vation of inducible nitric oxide (NO) synthase (iNOS), or cycloox-
ygenase, mitochondrial dysfunction, migration of neutrophils and leu-
kocytes [9–13]. This increased production of reactive oxygen species
and reactive nitrogen species during ABI may cause an unregulated
inflammatory response and further lead to structural and functional
injury of neurons [2]. We recently demonstrated, that amount of NO
and iNOS is increased in the lymphocytes of patients that have under-
gone CEA [14], which supported the notion that inflammatory response
may be responsible for the neuronal damage [8]. Also, it was shown
that both superoxide dismutase (SOD) and catalase (CAT) are involved
in the protection against neuronal damage after cerebral ischemia
[15,16]. We hypothesized that loss of SOD and CAT activities may
contribute to the DNA damage in lymphocytes caused by CEA.
To build further hypothesis regarding carotid artery occlusion, we
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used the topic-specific knowledgebase (KB) named DES-RedoxVasc
(https://www.cbrc.kaust.edu.sa/des-rv/) [17], focused on redox con-
trol of vascular systems. DES-RedoxVasc associated not only identifies
the potential association of NOS that we recently demonstrated was
increased in the lymphocytes of patients that have undergone CEA [14],
but also antioxidant activity, specifically SOD activity, and CAT ac-
tivity. This KB uses text-mining and statistical measures to provide
concepts of relevance to vascular biology that can be used to generate
hypotheses and potentially new knowledge. DES-RedoxVasc was used
to expand the concept of interest, “carotid artery occlusion”, with
molecular function, human anatomy, disease and human genes/protein
concepts enriched in vascular biology related literature. The network
illustration (Fig. 1) associates concepts such as “antioxidant activity”,
“ATPase activity”, “superoxide dismutase activity”, “caspase-3 ac-
tivity”, and “catalase activity”. These associations make sense as both
“carotid artery occlusion” and “brain ischemia” have been associated
with neuronal damage [2] and SOD and CAT activities protect against
neuronal damage after cerebral ischemia [15,16]. It was also demon-
strated that double-strand DNA breaks were induced by oxidative stress
in human carotid arteries with restenosis after carotid angioplasty and
stenting (CAS) [18].
Moreover, when CEA is used to treat carotid artery stenosis, CEA
may be followed by cognitive dysfunction [19], and neu-
trophil–lymphocyte ratio can be a predictor of cognitive dysfunction in
CEA patients. Specifically, patients with cognitive dysfunction had
significantly higher neutrophil–lymphocyte ratio than those without
cognitive dysfunction [19]. These reports suggest that low lymphocyte
counts may be responsible for the higher neutrophil–lymphocyte ratio,
and the low lymphocyte counts may be caused by DNA damage.
Thus we state Hypothesis: CEA increases the number of lymphocytes
with DNA damage through the increased free radicals, but this process
is also attributed to by the loss of SOD and/or CAT activities which
should be counteracting this effect.
Testing the hypothesis
In order to test the proposed hypothesis, we conducted a pilot study.
A group of five patients was admitted in Dedinje Cardiovascular
Institute, for surgery. Inclusion criteria for this pilot study was the
presence of carotid stenosis higher than 70%. During the surgical pro-
cedure, patients were under general anaesthesia, and jugular vein blood
was used for further analysis. Collection of blood was performed at
three different time points during CEA: one minute prior cross-clamping
the carotid artery (C1), one minute during cross-clamping the carotid
artery (C2), and one minute post reperfusion (C3).
To assess the effects of hypoxia/ischemia caused by CEA, we mea-
sured the levels of specific antioxidant enzymes SOD1, SOD2 and CAT
that the DES-RedoxVasc knowledgebase indicated may be involved in
this process. Accordingly, the levels of SOD1, SOD2 and CAT in the
lymphocytes of patients with carotid stenosis undergoing CEA, were
measured using Western blotting analysis as described [14,20]. The
mean values of SOD1, SOD2 and CAT for all patients are presented in
the Fig. 2A, 2B and 2C, respectively. Each figure indicate the in-
dependent mean values of SOD1, SOD2 and CAT levels, at three time
points. Similar changes in the levels of SOD1 and CAT were displayed at
the three time points. That is, the levels of SOD1 and CAT prior to C1
increased by 38% (p < 0.05) and 28% (p < 0.01), respectively,
during C2, but then decreased post reperfusion to levels almost similar
to those obtained prior to cross-clamping (Fig. 2A and 2C). On the other
hand, the levels of SOD2 was increased by 31% (p < 0.05) during C2
and this increase was maintained post reperfusion (34% (p < 0.05))
(Fig. 3B).
We also assessed the percentage of lymphocytes exhibiting DNA
damage in the test subjects using Comet assay [21,22]. The mean values
that represent the DNA damage in the lymphocytes of all patients are
presented in the Fig. 3. The number of lymphocytes with DNA damage
prior to cross-clamping increased by approximately 33% (p < 0.05)
during C2, but this number almost doubled (p < 0.001) post reperfu-
sion. The increase in the number of lymphcytes with DNA damage
during C2 moment until after reperfusion was also significant
(p < 0.01).
Discussion – where to go from here
We specifically focused on determining the changes in the levels of
antioxidant enzymes in peripheral blood lymphocytes collected from
carotid artery stenosis patients undergoing CEA; as a higher than
normal neutrophil–lymphocyte ratio, possibly caused by lower lym-
phocyte counts, indicates cognitive dysfunction in CEA patients [23].
Since inhibition of NO synthesis reduces infarct volume after transient
middle cerebral artery occlusion [24], the same lymphocyte samples
collected for this study was also used to determine that carotid
clamping leads to NO and iNOS overproduction. It was demonstrated
that plasma NO before carotid clamping is increased during cross-
clamping to more than three times in concentration, and post reperfu-
sion to more than nine times in concentration the initial value post
reperfusion [14]. This fact coupled with the knowledge that CEA in-
creases free radicals [25] also suggests a role for antioxidant activity
during CEA. Our results support this notion as levels of SOD1, SOD2
and CAT is significantly increased during cross-clamping (C2). Fur-
thermore, SOD enzymes process superoxide radical anions (O2−), and
in this process produce hydrogen peroxide (H2O2) as a by-product,
which can be further catalyzed to water and oxygen by CAT or glu-
tathione peroxidase [1]. This shows that SOD1 and CAT act in concert
to eradicate free radicals and in this manner, prevents or reduces re-
actions between NO and the O2− that produces the by-product
Fig. 1. DES-RedoxVasc network illustrating the relationship between
“carotid artery occlusion” and concepts from four different dictionaries
(with nodes pruned using a threshold on the connectivity of 1). The red circles
denote concepts from the “Molecular Function (GO)” dictionary; the green
circles denote concepts from the “Human Genes and Proteins (EntrezGene)”
dictionary; the maroon circles denote concepts from the “Human Anatomy”
dictionary; and the yellowish circles denote concepts from the “DOID Ontology
(Bioportal) Human Disease Ontology” dictionary.
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peroxynitrite, that has been implicated in the pathogenesis of many
diseases [1,26]. Thus, this study does not provide direct evidence but
rather suggests that levels of peroxynitrite increased as a result of CEA.
Forman et al., [27] has however demonstrated that ischemia produced
by bilateral occlusion of the common carotid arteries significantly in-
creases levels of cerebral iNOS, NO, and peroxynitrite, as well as levels
of plasma NO in rat models. Also, over-expressed SOD1 in transgenic
mice exerts neuroprotective effects in a state of cerebral ischemia [28],
while decreased expression of SOD1 causes hypertrophy of cerebral
arterioles [29]. Chan et al., [15] also observed that SOD1 achieved
neuroprotective effects, in a state of cerebral ischemia, by reducing the
apoptosis of hippocampal CA 1 cells.
Fig. 2A and C further show that the high levels of SOD1 and CAT is
not maintained post reperfusion, which further shows that they act in
concert and this action that eliminates O2− and H2O2 is not maintained.
Similar to SOD1, CAT was also shown to exert neuroprotective effects.
Armogida et al., [16] demonstrated that in the presence of H2O2, the
hippocampus of a transgenic mouse model over-expressing human CAT
exhibits increased resistance against simulated ischemia (oxygen/glu-
cose deprivation), and these mice also exhibited a reduced infarct size
after middle cerebral artery occlusion. It was also reported that CAT
expression in hypoxic pulmonary arterial smooth muscle is regulated by
adenosine monophosphate-activated protein kinase and Forkhead box
protein O1 [30]. However, the decrease in the level of CAT in lym-
phocytes post reperfusion may be a consequence of c-Abl and Arg not
only promoting CAT activity but also promoting CAT degradation in the
oxidative stress response [31].
The highly inducible SOD2 isoform was also shown to exert neu-
roprotective effects during cerebral ischemia [32]. That is, SOD2-defi-
cient mice with focal ischemia (induced via intraluminal middle cere-
bral artery occlusion) exhibited exacerbated cerebral infarction,
hemisphere enlargement, and mitochondrial injury [28]. Using the
same animal model, it was also demonstrated that deficiency of SOD2
leads to increased mitochondrial cytochrome c release, which is a cri-
tical step for apoptosis and subsequent DNA fragmentation in brain
cells, after permanent focal cerebral ischemia [33]. In contrast, over-
expression of mitochondrial SOD2 in neural cells prevents the accu-
mulation of peroxynitrite and apoptosis induced by Fe2+, amyloid beta-
peptide, and NO-generating agents [34]. Also, transgenic mice over-
expressing SOD2 exhibited reduced membrane lipid peroxidation,
Fig. 2. Levels of SOD1, SOD2, and CAT proteins in the lymphocytes of patients undergoing CEA at three different time points. The western blots depict the
levels of (A) SOD1 protein (n=3), (B) SOD2 protein (n=3), and (C) CAT protein (n=3). Results obtained for C2 and C3 are expressed as a percentage of the value
obtained for C1 and represent the mean± SEM (C2, C3 vs. C1; *p < 0.05; **p < 0.01). C1 - one minute prior cross-clamping the carotid artery; C2 – during cross-
clamping the carotid artery; C3 - one minute post reperfusion.
Fig. 3. DNA damage in the lymphocytes of patients undergoing CEA at
three different time points. Results are expressed as mean± SEM (C2, C3 vs.
C1 *p < 0.05; *** p < 0.001; C3 vs. C2 ## p < 0.01; n=5). C1 - one minute
prior cross-clamping the carotid artery; C2 – during cross-clamping the carotid
artery; C3 - one minute post reperfusion.
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protein nitration, and neuronal death after focal cerebral ischemia [34].
Fig. 2 further show that the significantly high levels of SOD2 was
maintained post reperfusion. Since the level of SOD1 and SOD2 have
been significantly increased in a short time, we assume that these in-
creases were due to the rapid induction of posttranslational modifica-
tions of previously synthesized proteins mediated by cytokines, growth
factors or effect of free radicals. Although SOD1 and SOD2 are very
effective in ameliorating oxidative stress, earlier pharmacokinetic stu-
dies in rats have revealed that they have a different half-life, which was
6–10min for SOD1 and 5–6 h for SOD2 [34]. This may be one of the
reasons for the increased level of SOD2, (but not SOD1 isoform) ob-
served post reperfusion in this study.
Damage of DNA in lymphocytes isolated from peripheral blood in
humans is often used as an indicator of genotoxicity in various patho-
logical states, including oxidative stress and inflammation [31]. In-
creased level of free radicals leads to the oxidation of nitrogenous bases
and single-strand breaks, while shear stress causes a breakdown of the
double helix, chromosomal fragmentation, translocation, and deletion
[35]. DNA damage can lead to inactivation of genes that are vital for
cell survival, including antioxidant enzymes genes, which makes cell
apoptosis virtually inevitable [36]. Fig. 3 shows that the amount of
lymphocytes with DNA damage was increased, both during carotid
clamping and post reperfusion. Thus, the number of lymphocytes with
DNA damage increased despite the increase in the levels of antioxidant
enzymes (SOD1, SOD2, and CAT). Nonetheless, SOD and CAT are in-
volved in the protection against neuronal damage after cerebral
ischemia [15,16]. Thus, their expression may not be fast enough or high
enough to prevent DNA damage in the lymphocytes, or they may not be
the antioxidant enzymes required to eliminate the free radicals pro-
duces during CEA. Thus, CEA increases the number of lymphocytes with
DNA damage through the increased free radicals, but this process is also
attributed to by the loss or lack of antioxidant enzymes that SOD should
be counteracting this effect. Thus, regulation of these enzymes in blood
might be one promising way to protect against the neurological damage
caused by oxidative stress related to ABI in patients undergoing CEA.
Conclusion
This study demonstrates that the levels of SOD1, SOD2, and CAT in
lymphocytes, and the number of DNA damaged lymphocytes is in-
creased in patients undergoing CEA. Changes in the level of antioxidant
enzymes simultaneously with DNA damage in lymphocytes of patients
undergoing CEA (together with our previous work demonstrating
overproduction of plasma NO [14]), confirm our assumptions that
oxidative stress could be responsible for neuronal injury as well as for
poor outcomes in patients undergoing CEA (Fig. 4). Future studies on a
larger population size is needed to confirm the proposed hypothesis and
to capture the role of antioxidant enzymes during CEA, and to de-
termine why we have patients undergoing CEA with poor outcome
despite the action of these antioxidant enzymes. We speculate that this
understanding may direct us to a combination of antioxidants that
could be used to pretreat patients undergoing CEA to reduce poor
outcome cases.
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